Business Description
Vetoquinol SA
SIC : 2834
ISIN : FR0004186856
Compare
Compare
Traded in other countries / regions
VETO.France8JM.Germany0O1O.UKVETOF.USA IPO Date
2006-11-16Description
Vetoquinol SA operates is a France-based firm serving in the healthcare market. Its focus lies on developing and marketing veterinary drugs mainly in the European region and to a certain extent in America and Asia. Its portfolio of drugs entails anti-infectives, anti- pain inflammatory drugs, cardiovascular and nephrology treatment intended mainly for pets and livestock.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 8.37 | |||||
| Equity-to-Asset | 0.76 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | 0.16 | |||||
| Interest Coverage | 84.7 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 5.7 | |||||
| Beneish M-Score | -2.57 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 7.4 | |||||
| 3-Year EBITDA Growth Rate | 10.8 | |||||
| 3-Year EPS without NRI Growth Rate | 58.5 | |||||
| 3-Year Book Growth Rate | 12.3 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 35.33 | |||||
| 9-Day RSI | 40.13 | |||||
| 14-Day RSI | 42.04 | |||||
| 6-1 Month Momentum % | 17.03 | |||||
| 12-1 Month Momentum % | 6.02 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.61 | |||||
| Quick Ratio | 1.86 | |||||
| Cash Ratio | 1.06 | |||||
| Days Inventory | 260.78 | |||||
| Days Sales Outstanding | 58.66 | |||||
| Days Payable | 146.25 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.84 | |||||
| Dividend Payout Ratio | 0.16 | |||||
| 3-Year Dividend Growth Rate | 28.2 | |||||
| Forward Dividend Yield % | 0.89 | |||||
| 5-Year Yield-on-Cost % | 1.62 | |||||
| Shareholder Yield % | 1.01 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 70.41 | |||||
| Operating Margin % | 14.69 | |||||
| Net Margin % | 10.5 | |||||
| FCF Margin % | 13.3 | |||||
| ROE % | 10.99 | |||||
| ROA % | 8.36 | |||||
| ROIC % | 13.17 | |||||
| ROC (Joel Greenblatt) % | 45.56 | |||||
| ROCE % | 14.63 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 20.13 | |||||
| PE Ratio without NRI | 19.22 | |||||
| Shiller PE Ratio | 27.87 | |||||
| Price-to-Owner-Earnings | 15.92 | |||||
| PEG Ratio | 1.22 | |||||
| PS Ratio | 2.11 | |||||
| PB Ratio | 2.12 | |||||
| Price-to-Tangible-Book | 3.76 | |||||
| Price-to-Free-Cash-Flow | 15.88 | |||||
| Price-to-Operating-Cash-Flow | 12.51 | |||||
| EV-to-EBIT | 12.71 | |||||
| EV-to-EBITDA | 8.81 | |||||
| EV-to-Revenue | 1.87 | |||||
| EV-to-FCF | 14.06 | |||||
| Price-to-Projected-FCF | 1.36 | |||||
| Price-to-DCF (Earnings Based) | 1.19 | |||||
| Price-to-DCF (FCF Based) | 1.17 | |||||
| Price-to-Median-PS-Value | 1.18 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.23 | |||||
| Price-to-Graham-Number | 1.79 | |||||
| Price-to-Net-Current-Asset-Value | 5.65 | |||||
| Earnings Yield (Greenblatt) % | 7.87 | |||||
| FCF Yield % | 6.29 | |||||
| Forward Rate of Return (Yacktman) % | 18.36 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vetoquinol SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 529.271 | ||
| EPS (TTM) (€) | 4.7 | ||
| Beta | 0.92 | ||
| Volatility % | 27.42 | ||
| 14-Day RSI | 42.04 | ||
| 14-Day ATR (€) | 2.448034 | ||
| 20-Day SMA (€) | 96.875 | ||
| 12-1 Month Momentum % | 6.02 | ||
| 52-Week Range (€) | 76.3 - 110 | ||
| Shares Outstanding (Mil) | 11.83 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vetoquinol SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vetoquinol SA Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vetoquinol SA Frequently Asked Questions
What is Vetoquinol SA(XPAR:VETO)'s stock price today?
The current price of XPAR:VETO is €94.60. The 52 week high of XPAR:VETO is €110.00 and 52 week low is €76.30.
When is next earnings date of Vetoquinol SA(XPAR:VETO)?
The next earnings date of Vetoquinol SA(XPAR:VETO) is .
Does Vetoquinol SA(XPAR:VETO) pay dividends? If so, how much?
The Dividend Yield %  of Vetoquinol SA(XPAR:VETO) is 0.84% (As of Today), Highest Dividend Payout Ratio of Vetoquinol SA(XPAR:VETO) was 0.31. The lowest was 0.1. And the median was 0.17. The  Forward Dividend Yield % of Vetoquinol SA(XPAR:VETO) is 0.89%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers